Alpha-Fetoprotein (AFP) Tumour Marker Test in Singapore

A request for an alpha-fetoprotein blood test, or a result that has come back above the reference range, usually raises the same question: what does this number actually mean?

FeM Surgery arranges AFP tumour marker testing and specialist review across six clinic locations in Singapore.

Dr Tan Yu-Meng
Director, Senior Consultant General Surgeon

Introduction

If you are looking into the AFP tumour marker test in Singapore, you are most likely in one of two situations. Either a doctor has requested the test as part of monitoring a known liver condition, or a routine screening panel has come back with an alpha-fetoprotein level higher than expected and you are trying to work out how worried to be.

Both situations deserve a straight answer, and the honest one is this. AFP is a useful marker, but it is a marker, not a diagnosis. A raised level does not confirm cancer, and a normal level does not exclude it. What the number does is tell your doctor where to look next.

This page explains what alpha-fetoprotein is, what the AFP blood test measures, how results are read in context, what a raised AFP may and may not indicate, and when a specialist review is appropriate.

What is Alpha-Fetoprotein (AFP)?

Alpha-fetoprotein is a protein produced by the liver and yolk sac of a developing foetus. Levels are very high at birth, fall sharply over the first year of life, and settle at a low baseline in healthy adults.

In adults, the liver largely stops producing it. When certain liver cells or germ cells begin dividing abnormally, they can switch that production back on, which is why alpha-fetoprotein appears in the blood again. That is the whole basis of the test.

AFP is also raised naturally in pregnancy, where it is measured for an entirely different purpose. If you are pregnant, an AFP result should be interpreted against pregnancy reference ranges, not adult ones.

For a general reference on the test itself, see the MedlinePlus entry on the alpha-fetoprotein tumour marker test from the United States National Library of Medicine, and the review of alpha-fetoprotein analysis.

What is the AFP Tumour Marker Test?

The AFP tumour marker test is a blood test that measures the concentration of alpha-fetoprotein in a sample of your blood, usually reported in nanograms per millilitre (ng/mL) or micrograms per litre (ug/L). The two units are numerically equivalent.

It is a single tube of blood, drawn from a vein in the arm. There is no fasting requirement, no injection of contrast, and no preparation beyond turning up. It is frequently ordered alongside other markers as part of a wider tumour marker blood test panel, and alongside imaging such as ultrasound.

It is worth being clear about the category. AFP is a supporting test. In current practice it is used with imaging and clinical assessment, not on its own.

Why the AFP Tumour Marker Test is Used

There are four established uses. Each answers a different question.

Surveillance in people at higher risk of liver cancer

In people with chronic hepatitis B, chronic hepatitis C or cirrhosis, AFP may be measured at intervals alongside ultrasound of the liver. The aim is to pick up hepatocellular carcinoma at a stage where more treatment options remain available. Surveillance is coordinated through the Gallstone Liver Centre at FeM Surgery.

Supporting a suspected diagnosis

Where imaging has shown a liver lesion, a markedly raised AFP adds weight to the picture. It rarely settles the question by itself, and biopsy or further imaging is often still required.

Monitoring response to treatment

For a cancer that was producing AFP at diagnosis, a falling level during treatment is a measurable sign that the treatment is having an effect. This is one of the situations where AFP is genuinely informative, because the patient acts as their own baseline.

Watching for recurrence after treatment

After treatment is completed, AFP is often tracked at intervals. A level that begins to climb again can flag recurrence before it becomes visible on a scan. Follow-up of this kind is managed through the Cancer Screening & Endoscopy Centre.

Symptoms and Concerns That Lead to an AFP Test

Most people do not arrive at this test because of dramatic symptoms. The common routes in are:

  • An abnormal result on a general health screening panel, with no symptoms at all.
  • Known chronic hepatitis B or C, or cirrhosis, where AFP forms part of scheduled surveillance.
  • Persistent discomfort or fullness in the upper right abdomen.
  • Unexplained weight loss, reduced appetite, or unusual fatigue that has not settled.
  • Yellowing of the skin or eyes, dark urine, or pale stools.
  • Swelling of the abdomen or ankles.
  • A testicular lump or swelling, or an ovarian mass found on a scan, where a germ cell tumour is being considered.
  • These are assessed with the Urology Centre where relevant.

None of these symptoms is specific to liver cancer, and most turn out to have another explanation. They are reasons to be assessed, not reasons to assume the worst.

Conditions Associated with a Raised AFP

FeM Surgery assesses and manages conditions in which alpha-fetoprotein is commonly measured, including:

  • Hepatocellular carcinoma (primary liver cancer)
  • Chronic hepatitis B and chronic hepatitis C
  • Cirrhosis and other chronic liver disease
  • Germ cell tumours of the testis or ovary, particularly yolk sac and mixed non-seminomatous types
  • Hepatoblastoma in children
  • Liver metastases from cancers arising elsewhere, including colorectal cancer
  • Benign liver regeneration following injury or inflammation
  • Rare inherited conditions such as hereditary tyrosinaemia and ataxia telangiectasia

These behave very differently from one another. A level of 15 ng/mL in someone with active hepatitis and a level of 15 ng/mL in someone with a lesion on ultrasound are not the same finding, and they do not lead to the same plan.

Who Should Consider an AFP Tumour Marker Test?

An AFP tumour marker test in Singapore is generally appropriate if any of the following apply to you:

  • You have chronic hepatitis B or hepatitis C. Chronic hepatitis B is the underlying cause in the majority of liver cirrhosis cases in Singapore and is the single largest contributor to liver cancer risk locally. See this review of liver disease in Singapore for the local picture.
  • You have cirrhosis from any cause, including alcohol-related liver disease and metabolic dysfunction-associated fatty liver disease.
  • You have a family history of liver cancer in a first-degree relative.
  • A liver lesion has been seen on ultrasound, CT or MRI and your doctor is working out what it is.
  • You are under treatment or follow-up for a cancer that produced AFP at the time of diagnosis.
  • A testicular or ovarian mass is being investigated and a germ cell tumour is in the differential.

AFP is not currently recommended as a general cancer screening test for people at average risk with no symptoms. Used that way it produces a high proportion of results that lead to anxiety and further testing without changing anything. That point is worth stating plainly, because the test is easy to add to a panel and frequently is.

When Should You See a Specialist?

Arrange a specialist review rather than waiting if:

  • Your AFP is raised and you have chronic hepatitis B, hepatitis C or cirrhosis.
  • Your AFP is rising across two or more tests, even if each individual value is only mildly above range. The trend carries more information than any single figure.
  • Your AFP is above 400 ng/mL. Levels in this range in a person with known liver disease are treated as significant and warrant prompt assessment.
  • An imaging scan has shown a liver lesion, whatever your AFP result is.
  • You have a testicular lump, an ovarian mass, or unexplained jaundice.

In our practice, the most common pattern is a mildly raised AFP found on a screening panel in a person with no symptoms and no known liver disease. In a large share of these cases the result reflects benign liver activity, and the appropriate next step is a repeat test with an ultrasound rather than an immediate assumption of cancer. The second most common pattern is the opposite problem: a person with hepatitis B who has a normal AFP, assumes all is well, and stops attending surveillance. Roughly a third of hepatocellular carcinomas do not produce enough AFP to raise the blood level, which is exactly why ultrasound is done alongside it.

Have a raised AFP result?

A specialist review sets your result against your liver history, your previous values and your imaging, and defines what happens next. Consultations are available with our cancer surgery team across six clinic locations in Singapore.

Preparation is minimal.

How to Prepare for the AFP Blood Test

No fasting is required

You can eat and drink normally beforehand. If the AFP test is being taken alongside other blood tests such as glucose or a lipid panel, those tests may require fasting, so check the combined instructions rather than assuming.

Tell us about your medications and supplements

Bring a list of everything you take, including over-the-counter supplements and traditional preparations. Some affect liver function and are relevant to how the result is read.

Tell us if you are pregnant or may be pregnant

AFP rises substantially in pregnancy as a normal physiological change. Without that information, an adult reference range will produce a misleading interpretation.

Bring previous results if you have them

Earlier AFP values, hepatitis serology and any prior scan reports make the current result far more useful. A single number in isolation is the weakest form of this test.

Wear sleeves that roll up easily

Blood is taken from a vein in the arm. If imaging is scheduled on the same visit, see our preparation advice for scans.

How the AFP Tumour Marker Test is Carried Out

The test itself takes a few minutes.

Registration and consent

You register at reception and confirm the tests requested.

Sample collection

The skin at the inner elbow or back of the hand is cleaned with an antiseptic wipe. A tourniquet is applied to the upper arm to make the vein easier to locate.

Blood draw

A sterile needle is inserted into the vein and a small volume of blood is drawn into a collection tube. Most people describe a brief sharp scratch.

Post-collection care

The needle is removed, pressure is applied, and a plaster is placed over the site.

Laboratory analysis

The labelled sample is sent for analysis. The laboratory measures AFP concentration using an immunoassay.

Results and review

Results are usually available within a few working days. Your doctor reviews them alongside your history, examination and any imaging, then discusses what they mean and what follows. You can return to normal activity immediately afterwards. There is no recovery period.

Understanding Your AFP Test ResultsUnderstanding Your AFP Test Results

AFP results are reported as a single number. Reading that number requires context: your age, whether you are pregnant, whether you have liver disease, what your previous values were, and what imaging shows.

Reference ranges vary between laboratories because different assays are used. Always read your result against the range printed on your own report rather than a figure found online. The values below are typical for adults in Singapore and are indicative only.

Category Typical adult range What it generally suggests
Normal Below about 10 ng/mL No evidence of AFP-producing activity. Does not exclude cancer, since a substantial proportion of liver cancers do not raise AFP.
Mildly raised About 10 to 100 ng/mL Most often reflects chronic hepatitis, cirrhosis or liver regeneration. Cancer is possible but is not the most likely explanation. Usually repeated with imaging.
Moderately raised About 100 to 400 ng/mL Requires assessment. Can occur in active liver disease and in cancer. Imaging and specialist review are appropriate.
Markedly raised Above about 400 ng/mL In a person with cirrhosis or chronic hepatitis and a liver lesion, this is treated as significant and prompts urgent assessment.
Pregnancy Rises through pregnancy Interpreted against gestational reference ranges for a different clinical purpose entirely.

Two points that matter more than the table. First, the trend beats the value. A level moving from 12 to 30 to 68 across three tests is more informative than a single reading of 68. Second, a normal AFP is reassuring but not conclusive, which is why surveillance pairs it with ultrasound.

AFP Levels and Liver Cancer: A Visual Guide

The chart below sets the four AFP bands side by side on a logarithmic scale, so the distance between a mildly raised result and a markedly raised one is visible rather than left to the imagination. It is the section most readers will look for first.

AFP Levels and What They May Indicate in Liver Cancer Assessment

Indicative alpa-fetoprotein ranges for non-pregnant adults. Logarithmic scale.


 

How to read it. Find your own figure on the scale, then read the band it falls into. Two qualifications apply to every band. Reference ranges differ between laboratories, so your own report is the authority. And a normal result sits in the grey band for a reason: it means no AFP-producing activity was detected, not that cancer has been excluded.

What each band means in practice

Band Range Usual interpretation and next step
Normal Below 10 ng/mL No AFP-producing activity detected. In people under surveillance for liver cancer, testing continues alongside ultrasound, because roughly a third of hepatocellular carcinomas do not raise AFP.
Mildly raised 10 to 100 ng/mL Most commonly chronic hepatitis B or C, cirrhosis, fatty liver disease or pregnancy. Usually repeated after an interval, with an ultrasound scan.
Moderately raised 100 to 400 ng/mL Warrants assessment. Seen in active liver disease and in cancer. Imaging and specialist review are appropriate rather than a repeat blood test alone.
Markedly raised Above 400 ng/mL In a person with cirrhosis or chronic hepatitis and a liver lesion on imaging, this is treated as significant and prompts urgent assessment.

The trend matters more than any single point on this chart. A value moving from 12 to 30 to 68 across three tests carries more information than one reading of 68, because it shows direction. This is why bringing previous results to a consultation changes what can be said about your case. Further background on how AFP is used in hepatocellular carcinoma is set out in the National Cancer Centre Singapore consensus guidelines and in a published review of the applications and limitations of AFP.

Which band does your result fall into?

If your AFP sits in the mildly, moderately or markedly raised band, the next step is interpretation in context rather than a repeat search. Our cancer surgery team reviews AFP results alongside liver function, hepatitis status and imaging.

What a High AFP Level May Indicate

Hepatocellular carcinoma (primary liver cancer)

The most commonly recognised cause of a markedly raised AFP. Risk is concentrated in people with cirrhosis or chronic viral hepatitis. Where imaging shows a lesion with characteristic features and AFP is high, the combination is often sufficient for diagnosis without biopsy. Management is coordinated through the Gallstone Liver Centre.

Germ Cell Tumours

Non-seminomatous germ cell tumours of the testis and ovary, particularly those with a yolk sac component, produce AFP. Here the marker is used for diagnosis, staging, treatment monitoring and follow-up. Testicular cases are assessed with the Urology Centre.

Chronic Hepatitis and Cirrhosis

Ongoing inflammation and regeneration in the liver commonly produce mild to moderate elevations. These fluctuate, often settle when the underlying inflammation is treated, and are the most frequent explanation for a mildly abnormal result.

Other Malignancies

Less commonly, stomach, pancreatic and lung cancers, and liver metastases from other primaries such as colorectal cancer, can raise AFP. Where peritoneal spread is involved, assessment may involve the Cancer Surgery & Peritonectomy Centre.

Non-cancerous Causes

Pregnancy, recovery from acute liver injury, and rare inherited conditions including hereditary tyrosinaemia and ataxia telangiectasia can all raise AFP. In children, a persistently high level is interpreted differently again, since the normal newborn baseline is high and falls gradually.

Cancer surgery and follow-up at FeM Surgery

Where a raised AFP leads on to a cancer diagnosis, assessment, surgery and follow-up are handled by the same team. Our surgeons cover liver, colorectal, breast, endocrine and urological cancer, so you are not passed between unconnected practices.

AFP Alongside Other Tumour Markers

AFP is rarely ordered alone. A combined tumour marker blood test panel is common, and each marker points in a different direction.

Category AFP CEA CA 19-9
Chiefly associated with Liver cancer, germ cell tumours Colorectal cancer, some lung and breast cancers Pancreatic and biliary tract cancers
Common benign causes of elevation Hepatitis, cirrhosis, pregnancy Smoking, inflammatory bowel disease, benign liver disease Gallstones, bile duct obstruction, pancreatitis
Main clinical strength Monitoring a known AFP-producing cancer over time Post-treatment follow-up in colorectal cancer Tracking response in known pancreatic cancer
Main limitation Misses roughly a third of liver cancers Not specific enough to diagnose on its own Absent in people lacking the Lewis antigen

Ordering a “cea afp test” together, or a wider panel, broadens what is being looked for. It does not make any individual marker more accurate, and it does increase the chance that at least one value comes back mildly abnormal for benign reasons. That trade-off is worth discussing before the blood is taken rather than afterwards. The National Cancer Centre Singapore overview of tumour marker blood tests sets out the same principle.

If your panel included other markers, we have separate pages on the CEA tumour marker test and the CA 19-9 tumour marker test.

For liver surveillance specifically, ultrasound is the companion test that matters. Where a lesion requires further characterisation or intervention, options are discussed through the Laparoscopic and Robotic Centre, the Day Surgery Centre and liver resection surgery.

What the AFP Test Can and Cannot Do

The AFP tumour marker test aims to:

  • Contribute to surveillance in people at raised risk of liver cancer, used together with ultrasound
  • Add supporting evidence where imaging has already raised a question
  • Provide a measurable way to track a cancer that was producing AFP at diagnosis
  • Give early warning of possible recurrence during follow-up
  • Help distinguish between types of germ cell tumour, which affects treatment planning

The test cannot:

  • Diagnose cancer on its own. No tumour marker can
  • Exclude cancer when the result is normal
  • Identify where in the body an AFP-producing tumour is located
  • Serve as a general cancer screen for people at average risk without symptoms

No test result, and no clinician, can promise a particular outcome. What a specialist review offers is a clear reading of what your result means in your circumstances and a defined plan for what happens next.

Risks, Limitations and Considerations

These are the risks common to any venepuncture and are uncommon:

  • Bruising at the puncture site
  • Brief discomfort as the needle enters and is withdrawn
  • Lightheadedness or fainting during or shortly after the draw
  • Infection at the site, which is rare

A raised AFP frequently has a benign explanation. Hepatitis, cirrhosis and pregnancy all elevate it. The consequence is anxiety and further testing that may, in retrospect, have been unnecessary. This is the main downside of ordering AFP without a clear reason.

A normal AFP does not rule out cancer. A substantial minority of hepatocellular carcinomas produce little or no AFP, and small early tumours often do not raise it at all. This is precisely why AFP is not used alone for surveillance.

The same figure carries different weight in different people. Reading an AFP result without knowing hepatitis status, liver function, previous values and imaging findings risks both false reassurance and unnecessary alarm.

In pregnancy the test is used for a different purpose against different reference ranges. An adult oncology interpretation applied to a pregnant patient will be wrong.
Your surgeon will discuss the limitations that apply specifically to your situation during consultation, including whether the test is the right one to be doing at all.

How Much Does an AFP Tumour Marker Test Cost in Singapore?

Cost depends on which components are required. A typical episode may include:

  • Specialist consultation
  • AFP blood test
  • Additional tumour markers, if a panel is requested
  • Liver function tests and hepatitis serology, where indicated
  • Ultrasound of the liver, or CT or MRI where further characterisation is needed
  • Follow-up review to discuss results

MediSave and insurance

Outpatient blood tests and specialist consultations are generally not MediSave claimable. Where investigation leads on to a day surgery or inpatient procedure, MediSave and MediShield Life or an Integrated Shield Plan may apply, depending on your policy, the procedure code and the ward or facility class. Our clinics are on a number of insurance panels for Singaporeans, Permanent Residents and foreigners. Please speak to our clinic staff before your visit, and confirm coverage directly with your insurer.

Dr Tan Yu-Meng

Dr Tan Yu-Meng

Director, Senior Consultant General Surgeon

Dr Tan continues to be one of few surgeons in Asia who perform specialized surgery for peritoneal malignancies in Asia.

  • MBBS (Bachelor of Medicine & Surgery, First Class Honors & Distinction at the University of London) 1994
  • RCSEd (Fellow of the Royal College of Surgeons Edinburgh) 1999
  • Further training in advanced HPB surgery and liver transplantation at the world renowned Liver Unit of Queen Elizabeth Hospital in Birmingham, United Kingdom.
  • Further training in living donor liver transplantation in Japan.

With his interest in gastrointestinal and hepatobiliary-pancreatic (GI-HPB) surgery and the treatment of cancer, Dr Tan joined the department of surgical oncology at the National Cancer Centre in 2003 as a consultant.

Dr Tan’s interest in the management of peritoneal surface malignancies was part of his effort in leading a multidisciplinary team from NCC to Washington Cancer Institute to adopt the techniques and protocols of peritonectomy and HIPEC (Sugarbaker procedure) from Dr Paul Sugarbaker in 2009.

The wider cancer surgery team

AFP points towards the liver and towards germ cell tumours. Where a result or a scan points elsewhere, these are the surgeons involved.

Surgeon Specialty Relevance to a tumour marker result
Dr Tan Yu-Meng Hepatobiliary, pancreatic and cancer surgery Raised AFP, liver lesions, liver resection, peritoneal malignancy
Dr Jonathan Foo Shuo Min Colorectal surgery Raised CEA, colorectal cancer, colonoscopy and gastroscopy
Dr Felicia Tan Li Sher Breast and general surgery Breast lumps and breast cancer assessment
Dr Jesse Hu Breast, thyroid and endocrine surgery Breast and thyroid cancer, endocrine tumours
Dr Png Keng Siang Urology and robotic surgery Testicular and germ cell tumours, prostate and bladder cancer

Profiles: Dr Tan Yu-Meng | Dr Jonathan Foo Shuo Min | Dr Felicia Tan Li Sher | Dr Jesse Hu | Dr Png Keng Siang | View all our specialists

Speak to a cancer specialist about your result

Bring your AFP result, any previous values, your hepatitis status and any recent scan reports. That is enough to move from a number on a page to a defined plan.

Alpha-Fetoprotein (AFP) Tumour Marker Test

Frequently Asked
Questions

What does a high AFP level mean?

A high alpha-fetoprotein level means AFP-producing activity is present somewhere in the body. The most common explanations are chronic hepatitis, cirrhosis and pregnancy. Liver cancer and germ cell tumours are the significant causes that need to be excluded. The height of the level, the trend across tests and your imaging findings together determine what it means for you.

What is a normal AFP level?

For non-pregnant adults, most laboratories in Singapore use a reference range of below approximately 10 ng/mL. Ranges differ between laboratories because assays differ, so read your result against the range printed on your own report.

Does a raised AFP mean I have cancer?

No. Most mildly raised AFP results in Singapore turn out to reflect benign liver conditions, particularly chronic hepatitis B and fatty liver disease. A raised result is a reason to be assessed, not a diagnosis.

Can I have liver cancer with a normal AFP?

Yes. Roughly a third of hepatocellular carcinomas do not raise AFP, and small early tumours often do not. This is why liver surveillance in people at higher risk pairs AFP with ultrasound rather than relying on the blood test alone.

How do I prepare for the AFP tumour marker test?

No fasting or dietary change is needed. Tell your doctor about all medications and supplements you take, and tell us if you are pregnant or may be pregnant, since AFP rises naturally in pregnancy.

How soon will I get my AFP results?

Results are usually available within a few working days, depending on the laboratory. Your doctor will review them alongside your history and any imaging, and discuss what they mean and what happens next.

What is the difference between an AFP test and a CEA test?

They track different cancers. AFP is chiefly associated with liver cancer and germ cell tumours. CEA is chiefly associated with colorectal cancer. They are sometimes ordered together as part of a wider tumour marker panel, which widens the search but does not make either marker more accurate.

Is the AFP test painful?

It is a standard blood draw from a vein in the arm. Most people describe a brief sharp scratch. Bruising at the site is the most common after-effect and settles on its own.

How often should I have an AFP test if I have hepatitis B?

Surveillance intervals depend on your liver condition, your imaging findings and your other risk factors, and are set individually. Testing at intervals alongside ultrasound is the usual approach. Your specialist will set the schedule that applies to you.

Are there risks associated with the AFP tumour marker test?

The physical risks are those of any blood test: bruising, brief discomfort, occasional lightheadedness, and rarely infection at the puncture site. The more meaningful risk is interpretive, meaning a benign elevation causing unnecessary worry, or a normal result creating false reassurance.

Visit FeM Surgery

If you are considering an AFP tumour marker test in Singapore, or you have a result you would like read properly in context, Dr Tan Yu-Meng and the team at FeM Surgery are available for consultation.

Visit Our
Clinic Locations

For other matters, you can get in touch with us through our phone number, email or by submitting a message through our contact form.

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment






    image

    For faster response, Call Us

    (65) 6733 3383